Impact of a methicillin-resistant Staphylococcus aureus active surveillance program on contact precaution utilization in a surgical intensive care unit

Critical Care Medicine

Volumn 35, Issue 2, 2007, Pages 430-434

  Warren, David K ^a,b   Guth, Rebecca M ^a   Coopersmith, Craig M ^a   Merz, Liana R ^a   Zack, Jeanne E ^c   Fraser, Victoria J ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

^c MISSOURI BAPTIST MEDICAL CENTER   (United States)

Author keywords

Antimicrobial resistance; Infection control; Intensive care unit; Methicillin resistance; Patient isolation; Staphylococcus aureus

Indexed keywords

ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SURVEILLANCE; HOSPITAL BED CAPACITY; HUMAN; HUMAN TISSUE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; VANCOMYCIN RESISTANT ENTEROCOCCUS;

HUMANS; INTENSIVE CARE UNITS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; POPULATION SURVEILLANCE; PROGRAM EVALUATION; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGERY DEPARTMENT, HOSPITAL; UNIVERSAL PRECAUTIONS;

EID: 33846421618     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000253813.98431.28     Document Type: Article

References (24)

1. Burke J: Infection control-A problem for patient safety. N Engl J Med 2003; 348: 651-656
2. Tiemersma EW, Bronzwaer SL, Lyytikainen O, et al: Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004; 10:1627-1634
3. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32: 470-485
4. Guideline for isolation precautions in hospitals. Part II: Recommendations for isolation precautions in hospitals. Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1996; 24:32-52
5. Strausbaugh LJ, Jacobson C, Sewell DL, et al: Methicillin-resistant Staphylococcus aureus in extended-care facilities: Experiences in a Veterans' Affairs nursing home and a review of the literature. Infect Control Hosp Epidemiol 1991; 12:36-45
6. Muto CA, Jernigan JA, Ostrowsky BE, et al: SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003; 24: 362-386
7. Jernigan J, Titus M, Groschel D, et al: Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996; 143: 496-504
8. Kirkland K, Weinstein J: Adverse effects of contact isolation. Lancet 1999; 354:1177-1178
9. Kim T, Oh PI, Simor AE: The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol 2001; 22:99-104
10. Evans H, Shaffer M, Hughes M, et al: Contact Isolation in surgical patients: A barrier to care? Surgery 2004; 134:180-188
11. Stelfox H, Bates D, Redelmeier D: Safety of patients isolated for infection control. JAMA 2003; 290:1899-1905
12. Saint S, Higgins L, Nallamothu B, et al: Do physicians examine patients in contact isolation less frequently? A brief report. Am J Infect Control 2003; 31:354-356
13. Karchmer T, Durbin L, Simonton B, et al: Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2002; 51:126-132
14. Chaix C, Durand-Zaleski I, Alberti C, et al: Control of endemic methicillin-resistant Staphylococcus aureus: A cost-benefit analysis in an intensive care unit. JAMA 1999; 282:1745-1751
15. Newton J, Constable D, Senior V: Patients' perceptions of methicillin-resistant Staphylococcus aureus and source isolation: A qualitative analysis of source-isolated patients. J Hosp Infect 2001; 48:275-280
16. Cepeda JA, Whitehouse T, Cooper B, et al: Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: Prospective two-centre study. Lancet 2005; 365:295-304
17. Huskins WC, Goldmann DA: Controlling methicillin-resistant Staphylococcus aureus, aka "Superbug." Lancet 2005; 365:273-275
18. Klein BS, Perloff WH, Maki DG: Reduction of nosocomial infection during pediatric intensive care by protective isolation. N Engl J Med 1989; 320:1714-1721
19. Lucet JC, Paoletti X, Lolom I, et al: Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med 2005; 31:1051-1057
20. Davis KA, Stewart JJ, Crouch HK, et al: Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 2004; 39:776-782
21. Merrer J, Santoli F, Appere de Vecchi C, et al: "Colonization pressure" and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol 2000; 21: 718-723
22. Bonten MJ, Slaughter S, Ambergen AW, et al: The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: An important infection control variable. Arch Intern Med 1998; 158:1127-1132
23. Warren DK, Liao RS, Merz LR, et al: Detection of methicillin-resistant Staphylococcus aureus directly from nasal swab specimens by a real-time PCR assay. J Clin Microbiol 2004; 42:5578-5581
24. Saiman L, O'Keefe M, Graham PL, III, et al: Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis 2003; 37:1313-1319